-
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Moderate Buy" by Analysts
ソース: Buzz FX / 24 2 2025 03:13:19 America/New_York
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat February 24, 2025 Share Link copied to clipboard. Shares of Intellia Therapeutics, Inc.
Read more...